Mirta Mittelstedt Leal de Sousa

Mirta Mittelstedt Leal de Sousa

Auto-generated profile, based on publicly available information

Mirta Mittelstedt Leal de Sousa

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7028 Trondheim, Norway

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Open access
AQAna Quiles-Jiménez
Ana Quiles-Jiménez
IGIda Gregersen
Ida Gregersen
MSMirta Mittelstedt Leal de Sousa
Mirta Mittelstedt Leal de Sousa
AAAzhar Abbas
Azhar Abbas
XKXiang Yi Kong
Xiang Yi Kong
BHBente Halvorsen
Bente Halvorsen
More than 170 post-transcriptional RNA modifications regulate the localization, processing and function of cellular RNAs, and aberrant RNA modifications have been linked to a range of human diseases. The RNA modification landscape in atherosclerosis, the main underlying cause of cardiovascular diseases, is still largely unknown. We used mass spectrometry to analyse a selection of RNA-modifying enzymes and the N6-methyladenosine (m6A) in carotid atherosclerotic lesion samples representing early and advanced stages of atherosclerosis as compared to non-atherosclerotic arteries from healthy controls. (i) the detection of different levels of several enzymes involved in methylations occurring in rRNA and mRNA; (ii) these findings included changes in the levels of methyltransferases ('writers'), binding proteins ('readers') and demethylases ('erasers') during atherosclerosis as compared to non-atherosclerotic control arteries, with generally the most prominent differences in samples from early atherosclerotic lesions; and (iii) these changes were accompanied by a marked downregulation of m6A in rRNA, the most abundant and well-studied modification in mRNA with a wide range of effects on cell biology. We show for the first time that RNA-modifying enzymes and the well-studied RNA modification m6A are differentially regulated in atherosclerotic lesions, which potentially could help creating new prognostic and treatment strategies.

2 July 2019 in The Plant Cell
Verified
Journal Article
Closed access
PDF file
HPHarriet T. Parsons
Harriet T. Parsons
TSTim J. Stevens
Tim J. Stevens
HMHeather E. McFarlane
Heather E. McFarlane
SVSilvia Vidal-Melgosa
Silvia Vidal-Melgosa
JGJohannes Griss
Johannes Griss
KLKathryn Lilley
Kathryn Lilley
The order of enzymatic activity across Golgi cisternae is essential for complex molecule biosynthesis. However, an inability to separate Golgi cisternae has meant that the cisternal distribution of most resident proteins, and their underlying localization mechanisms, are unknown. Here, we exploit differences in surface charge of intact cisternae to perform separation of early to late Golgi subcompartments. We determine protein and glycan abundance profiles across the Golgi; over 390 resident proteins are identified, including 136 new additions, with over 180 cisternal assignments. These assignments provide a means to better understand the functional roles of Golgi proteins and how they operate sequentially. Protein and glycan distributions are validated in vivo using high-resolution microscopy. Results reveal distinct functional compartmentalization among resident Golgi proteins. Analysis of transmembrane proteins shows several sequence-based characteristics relating to pI, hydrophobicity, Ser abundance, and Phe bilayer asymmetry that change across the Golgi. Overall, our results suggest that a continuum of transmembrane features, rather than discrete rules, guide proteins to earlier or later locations within the Golgi stack.

4 August 2011 in Proteome Science
Verified
Journal Article
Open access
PDF file
MSMirta Ml Sousa
Mirta Ml Sousa
KSKristian W Steen
Kristian W Steen
LHLars Hagen
Lars Hagen
GSGeir Slupphaug
Geir Slupphaug
Background: Immunoprecipitation and subsequent 2D-PAGE/mass spectrometry are powerful tools to study post-translational protein modifications. Often disregarded in this workflow is the impact of the chemical cross-linker upon antibody affinity, as well as incomplete elution of primary target protein in buffers commonly used in 2D-PAGE. This may impede detection of non-abundant protein isoforms. Results: Here we have compared cross-linking of antibodies to Dynabeads® Protein A by using DMP or BS3, as well as the efficiency of various target elution buffers prior to 2D-PAGE separation. BS3 cross-linking generally resulted in less non-specific binding than DMP, whereas DMP cross-linking gave overall higher yield of target protein. Regardless of the cross-linker used, incomplete elution of target protein was observed with conventional glycine- or urea-based buffers. Conversely, complete elution was obtained with 2% hot SDS and subsequent dilution in urea buffer containing 4% CHAPS, to 0.2% final SDS yielded perfectly focused gels suitable for mass spectrometry analysis. Conclusion: Careful choice of Ig cross-linker as well as efficient elution of target protein in SDS prior to downstream 2D-PAGE may be key factors to analyze low-abundance proteins enriched by magnetic bead immunoprecipitation.

26 June 2015 in Basic Research in Cardiology
Verified
Journal Article
Closed access
PDF file
NRNatale Rolim
Natale Rolim
KSKristine Skårdal
Kristine Skårdal
Morten HøydalMorten Høydal
Morten Høydal
MSMirta M. L. Sousa
Mirta M. L. Sousa
VMVegard Malmo
Vegard Malmo
UWUlrik Wisløff
Ulrik Wisløff

Verified
Journal Article
Open access
PDF file
MSMirta Mittelstedt Leal de Sousa
Mirta Mittelstedt Leal de Sousa
JYJing Ye
Jing Ye
LLLuisa Luna
Luisa Luna
GHGunn Annette Hildrestrand
Gunn Annette Hildrestrand
KBKarine Bjørås
Karine Bjørås
TRTorstein Baade Røe
Torstein Baade Røe
The human brain requires a high rate of oxygen consumption to perform intense metabolic activities, accounting for 20% of total body oxygen consumption. This high oxygen uptake results in the generation of free radicals, including reactive oxygen species (ROS), which, at physiological levels, are beneficial to the proper functioning of fundamental cellular processes. At supraphysiological levels, however, ROS and associated lesions cause detrimental effects in brain cells, commonly observed in several neurodegenerative disorders. In this review, we focus on the impact of oxidative DNA base lesions and the role of DNA glycosylase enzymes repairing these lesions on brain function and disease. Furthermore, we discuss the role of DNA base oxidation as an epigenetic mechanism involved in brain diseases, as well as potential roles of DNA glycosylases in different epigenetic contexts. We provide a detailed overview of the impact of DNA glycosylases on brain metabolism, cognition, inflammation, tissue loss and regeneration, and age-related neurodegenerative diseases based on evidence collected from animal and human models lacking these enzymes, as well as post-mortem studies on patients with neurological disorders.